WDR31
gene geneOn this page
Also known as FLJ35921
Summary
WDR31 (WD repeat domain 31, HGNC:21421) is a protein-coding gene on chromosome 9q32, encoding WD repeat-containing protein 31 (Q8NA23).
This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene but the biological validity of some variants has not been determined.
Source: NCBI Gene 114987 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 57 total — 1 likely-pathogenic
- MANE Select transcript:
NM_001012361
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21421 |
| Approved symbol | WDR31 |
| Name | WD repeat domain 31 |
| Location | 9q32 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ35921 |
| Ensembl gene | ENSG00000148225 |
| Ensembl biotype | protein_coding |
| OMIM | 620951 |
| Entrez | 114987 |
Gene structure
Transcript identifiers
Ensembl transcripts: 25 — 23 protein_coding, 1 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000341761, ENST00000374193, ENST00000461942, ENST00000465205, ENST00000465979, ENST00000865155, ENST00000865156, ENST00000865157, ENST00000865158, ENST00000865159, ENST00000865160, ENST00000865161, ENST00000865162, ENST00000944262, ENST00000944263, ENST00000944264, ENST00000944265, ENST00000944266, ENST00000944267, ENST00000944268, ENST00000944269, ENST00000944270, ENST00000944271, ENST00000944272, ENST00000944273
RefSeq mRNA: 3 — MANE Select: NM_001012361
NM_001006615, NM_001012361, NM_145241
CCDS: CCDS35110, CCDS6792
Canonical transcript exons
ENST00000374193 — 11 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001091091 | 113336288 | 113336440 |
| ENSE00001838862 | 113340217 | 113340275 |
| ENSE00003415780 | 113313222 | 113316909 |
| ENSE00003510339 | 113321511 | 113321578 |
| ENSE00003542239 | 113320357 | 113320498 |
| ENSE00003650114 | 113330984 | 113331116 |
| ENSE00003663509 | 113322811 | 113322911 |
| ENSE00003689702 | 113328881 | 113328955 |
| ENSE00003694650 | 113318475 | 113318637 |
| ENSE00003729783 | 113323011 | 113323155 |
| ENSE00003752182 | 113331907 | 113332050 |
Expression profiles
Bgee: expression breadth ubiquitous, 162 present calls, max score 83.72.
FANTOM5 (CAGE): breadth broad, TPM avg 0.6774 / max 16.1639, expressed in 444 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 102095 | 0.5500 | 339 |
| 102096 | 0.1274 | 37 |
Top tissues by expression
247 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 83.72 | gold quality |
| bronchial epithelial cell | CL:0002328 | 76.49 | gold quality |
| bronchus | UBERON:0002185 | 74.88 | gold quality |
| heart left ventricle | UBERON:0002084 | 74.32 | gold quality |
| islet of Langerhans | UBERON:0000006 | 74.17 | gold quality |
| cardiac ventricle | UBERON:0002082 | 73.62 | gold quality |
| right adrenal gland | UBERON:0001233 | 73.32 | gold quality |
| stromal cell of endometrium | CL:0002255 | 73.05 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 73.04 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 72.88 | gold quality |
| left adrenal gland | UBERON:0001234 | 72.10 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 71.47 | gold quality |
| apex of heart | UBERON:0002098 | 71.33 | gold quality |
| adrenal gland | UBERON:0002369 | 70.43 | gold quality |
| heart | UBERON:0000948 | 69.95 | gold quality |
| ventricular zone | UBERON:0003053 | 69.95 | gold quality |
| right uterine tube | UBERON:0001302 | 69.80 | gold quality |
| oviduct epithelium | UBERON:0004804 | 69.79 | gold quality |
| cortical plate | UBERON:0005343 | 69.75 | gold quality |
| adrenal cortex | UBERON:0001235 | 69.57 | gold quality |
| prefrontal cortex | UBERON:0000451 | 68.99 | gold quality |
| upper arm skin | UBERON:0004263 | 68.93 | gold quality |
| right atrium auricular region | UBERON:0006631 | 68.33 | gold quality |
| colonic epithelium | UBERON:0000397 | 68.25 | silver quality |
| smooth muscle tissue | UBERON:0001135 | 67.86 | gold quality |
| cardiac atrium | UBERON:0002081 | 67.70 | gold quality |
| pancreas | UBERON:0001264 | 67.17 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 66.82 | gold quality |
| right testis | UBERON:0004534 | 66.62 | gold quality |
| fallopian tube | UBERON:0003889 | 66.48 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.19 |
| E-ENAD-27 | no | 3.91 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
102 targeting WDR31, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-12118 | 100.00 | 65.88 | 1270 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-7110-3P | 100.00 | 73.18 | 2486 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-6891-5P | 99.98 | 66.53 | 1372 |
| HSA-MIR-3173-3P | 99.98 | 66.49 | 1217 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-1343-3P | 99.89 | 66.78 | 1815 |
| HSA-MIR-6783-3P | 99.89 | 67.92 | 2059 |
| HSA-MIR-221-5P | 99.86 | 65.45 | 1052 |
| HSA-MIR-8073 | 99.86 | 65.21 | 1118 |
| HSA-MIR-629-3P | 99.85 | 67.99 | 1875 |
| HSA-MIR-6739-5P | 99.80 | 67.87 | 2806 |
| HSA-MIR-4694-3P | 99.79 | 69.53 | 2640 |
| HSA-MIR-4713-5P | 99.78 | 67.80 | 1794 |
| HSA-MIR-4319 | 99.76 | 69.83 | 2586 |
| HSA-MIR-6733-5P | 99.74 | 67.94 | 2759 |
| HSA-MIR-33A-3P | 99.70 | 70.27 | 3362 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-5004-5P | 99.68 | 66.63 | 1294 |
| HSA-MIR-6892-3P | 99.68 | 66.40 | 1178 |
| HSA-MIR-580-3P | 99.67 | 69.23 | 1841 |
| HSA-MIR-7152-5P | 99.60 | 69.33 | 2094 |
| HSA-MIR-4261 | 99.59 | 70.30 | 3415 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | wdr31 | ENSDARG00000073808 |
| mus_musculus | Wdr31 | ENSMUSG00000028391 |
| rattus_norvegicus | Wdr31 | ENSRNOG00000014869 |
| caenorhabditis_elegans | WBGENE00020231 |
Protein
Protein identifiers
WD repeat-containing protein 31 — Q8NA23 (reviewed: Q8NA23)
All UniProt accessions (3): Q8NA23, C9JWF1, F8WDK4
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8NA23-1 | 1 | yes |
| Q8NA23-2 | 2 |
RefSeq proteins (3): NP_001006616, NP_001012361, NP_660284 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001680 | WD40_rpt | Repeat |
| IPR015943 | WD40/YVTN_repeat-like_dom_sf | Homologous_superfamily |
| IPR019775 | WD40_repeat_CS | Conserved_site |
| IPR020472 | WD40_PAC1 | Repeat |
| IPR036322 | WD40_repeat_dom_sf | Homologous_superfamily |
| IPR040066 | WDR31 | Family |
Pfam: PF00400
UniProt features (10 total): repeat 7, chain 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NA23-F1 | 85.43 | 0.78 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 74 (showing top):
MARSON_BOUND_BY_FOXP3_STIMULATED, MARSON_BOUND_BY_FOXP3_UNSTIMULATED, YOSHIMURA_MAPK8_TARGETS_UP, GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_DN, DODD_NASOPHARYNGEAL_CARCINOMA_DN, MEISSNER_NPC_HCP_WITH_H3K4ME2, FIGUEROA_AML_METHYLATION_CLUSTER_4_UP, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B, LIM_MAMMARY_STEM_CELL_DN, DURAND_STROMA_NS_UP, CRX_DN.V1_UP, NRL_DN.V1_DN, ALKBH3_TARGET_GENES, DIDO1_TARGET_GENES, HDAC4_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
3252 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| WDR31 | SMKR1 | H3BMG3 | 524 |
| WDR31 | PGAP4 | Q9BRR3 | 461 |
| WDR31 | NPIPB9 | F8W1W9 | 447 |
| WDR31 | TMEM273 | Q5T292 | 445 |
| WDR31 | RGS9BP | Q6ZS82 | 435 |
| WDR31 | ANKRD66 | B4E2M5 | 418 |
| WDR31 | HEATR5B | Q9P2D3 | 417 |
| WDR31 | STX2 | P32856 | 415 |
| WDR31 | ACP7 | Q6ZNF0 | 406 |
| WDR31 | SERTAD4 | Q9NUC0 | 373 |
| WDR31 | TTC23 | Q5W5X9 | 372 |
| WDR31 | WDR70 | Q9NW82 | 371 |
| WDR31 | FAM169A | Q9Y6X4 | 363 |
| WDR31 | DYNC2I2 | Q96EX3 | 350 |
| WDR31 | EIF6 | P56537 | 349 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| LAMP2 | WDR31 | psi-mi:“MI:0915”(physical association) | 0.400 |
| WDR31 | NUDC | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (1): WDR31 (Synthetic Lethality)
ESM2 similar proteins: A0A1L8HX76, A0JP70, A4IG72, A7E3S5, A7Z052, D3ZW91, E9PY46, P57081, Q05B17, Q0P5H9, Q15061, Q32P44, Q3SZD4, Q3U821, Q499N3, Q4VBE8, Q5BK48, Q5F3K4, Q5RB07, Q5RBH8, Q5RD06, Q5XFW6, Q68EI0, Q6DFC6, Q6KAU8, Q6PFM9, Q6PGF3, Q6ZQL4, Q7ZVF0, Q7ZVR1, Q7ZY78, Q8BH57, Q8C5V5, Q8IWA0, Q8N0Z6, Q8NA23, Q8NAA4, Q8VC03, Q969R8, Q96KV7
Diamond homologs: A6H603, O14011, O22785, P25635, P32523, Q08E38, Q10051, Q55AR8, Q5ZMA2, Q7KWK5, Q86H45, Q8NA23, Q94BR4, Q99KP6, Q9AV81, Q9JMJ4, Q9UMS4, Q9HAD4, Q9JHB4, Q3UDP0, Q21215
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
57 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 1 |
| Uncertain significance | 42 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1527542 | GRCh37/hg19 9q31.2-32(chr9:109265628-117650999) | Likely pathogenic |
SpliceAI
1828 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:113320335:TGG:T | donor_gain | 1.0000 |
| 9:113320499:C:CC | acceptor_gain | 1.0000 |
| 9:113336441:C:CC | acceptor_gain | 1.0000 |
| 9:113339081:C:A | donor_gain | 1.0000 |
| 9:113320495:TAAT:T | acceptor_gain | 0.9900 |
| 9:113320496:AATC:A | acceptor_loss | 0.9900 |
| 9:113320497:AT:A | acceptor_gain | 0.9900 |
| 9:113320498:TCTG:T | acceptor_loss | 0.9900 |
| 9:113320499:CTGAA:C | acceptor_loss | 0.9900 |
| 9:113322816:T:A | donor_gain | 0.9900 |
| 9:113336286:ACCC:A | donor_gain | 0.9900 |
| 9:113336287:CCCC:C | donor_gain | 0.9900 |
| 9:113336439:CA:C | acceptor_gain | 0.9900 |
| 9:113318638:C:CC | acceptor_gain | 0.9800 |
| 9:113323008:TAC:T | donor_loss | 0.9800 |
| 9:113323009:AC:A | donor_loss | 0.9800 |
| 9:113323010:C:A | donor_loss | 0.9800 |
| 9:113328952:CTGT:C | acceptor_gain | 0.9800 |
| 9:113330988:T:C | donor_gain | 0.9800 |
| 9:113336279:ATTAC:A | donor_loss | 0.9800 |
| 9:113336280:TTAC:T | donor_loss | 0.9800 |
| 9:113336281:TACT:T | donor_loss | 0.9800 |
| 9:113336282:ACTT:A | donor_loss | 0.9800 |
| 9:113336283:CTTAC:C | donor_loss | 0.9800 |
| 9:113336284:T:TG | donor_loss | 0.9800 |
| 9:113336285:TACCC:T | donor_loss | 0.9800 |
| 9:113336286:A:G | donor_loss | 0.9800 |
| 9:113336286:AC:A | donor_gain | 0.9800 |
| 9:113336287:CC:C | donor_gain | 0.9800 |
| 9:113336436:TTGCA:T | acceptor_gain | 0.9800 |
AlphaMissense
2405 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:113323120:A:C | S120R | 0.998 |
| 9:113323120:A:T | S120R | 0.998 |
| 9:113323122:T:G | S120R | 0.998 |
| 9:113323092:A:G | W130R | 0.991 |
| 9:113323092:A:T | W130R | 0.991 |
| 9:113318493:A:G | W309R | 0.990 |
| 9:113318493:A:T | W309R | 0.990 |
| 9:113318634:A:G | W262R | 0.990 |
| 9:113318634:A:T | W262R | 0.990 |
| 9:113331003:A:T | V77D | 0.988 |
| 9:113323034:A:T | V149D | 0.986 |
| 9:113323090:C:A | W130C | 0.985 |
| 9:113323090:C:G | W130C | 0.985 |
| 9:113318525:G:T | A298D | 0.984 |
| 9:113320494:A:G | W215R | 0.984 |
| 9:113320494:A:T | W215R | 0.984 |
| 9:113322888:A:G | S165P | 0.984 |
| 9:113322890:C:T | G164D | 0.984 |
| 9:113323118:G:T | A121D | 0.981 |
| 9:113331001:A:G | S78P | 0.979 |
| 9:113316824:A:C | S343R | 0.977 |
| 9:113316824:A:T | S343R | 0.977 |
| 9:113316826:T:G | S343R | 0.977 |
| 9:113318598:A:C | Y274D | 0.977 |
| 9:113318632:C:A | W262C | 0.975 |
| 9:113318632:C:G | W262C | 0.975 |
| 9:113322882:C:G | D167H | 0.974 |
| 9:113323116:A:G | S122P | 0.974 |
| 9:113330997:C:T | G79E | 0.974 |
| 9:113318491:C:A | W309C | 0.973 |
dbSNP variants (sampled 300 via entrez): RS1000177032 (9:113325262 G>A), RS1000228024 (9:113324844 G>A), RS1000332176 (9:113316393 C>T), RS1000535358 (9:113339472 T>C), RS1000662775 (9:113335906 G>T), RS1000969956 (9:113313744 C>A,T), RS1000992456 (9:113339208 A>T), RS1001160945 (9:113323219 A>G), RS1001676202 (9:113316664 C>T), RS1001793419 (9:113329157 G>T), RS1001855235 (9:113323811 A>C), RS1001909245 (9:113323541 C>G,T), RS1002134520 (9:113316878 T>C), RS1002207766 (9:113337835 T>C,G), RS1002323294 (9:113329042 C>T)
Disease associations
OMIM: gene MIM:620951 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST90002407_122 | White blood cell count | 3.000000e-11 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| pentanal | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | decreases expression | 1 |
| jinfukang | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Folic Acid | decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Valproic Acid | increases expression | 1 |
| Gold Compounds | decreases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Particulate Matter | increases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.